“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart
Article: P08 RESOLVING DOAC INTERFERENCE ON APTT, PT AND LUPUS ANTICOAGULANT TESTING BY THE USE OF ACTIVATED CARBON
P08 RESOLVING DOAC INTERFERENCE ON APTT, PT AND LUPUS ANTICOAGULANT TESTING BY THE USE OF ACTIVATED CARBON
Reviews
There are no reviews yet.
Be the first to review “Article: P08 RESOLVING DOAC INTERFERENCE ON APTT, PT AND LUPUS ANTICOAGULANT TESTING BY THE USE OF ACTIVATED CARBON” Cancel reply
Reviews
There are no reviews yet.